Upgrade to SI Premium - Free Trial

Ironwood Pharma (IRWD)

3.57 +0.02 (0.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Ironwood Pharmaceuticals stock falls on CEO transition news October 16, 2026 11:47 AM - StreetInsider Form 8-K IRONWOOD PHARMACEUTICALS For: Oct 12 October 16, 2026 7:31 AM - SEC Filing Ironwood Pharmaceuticals names Tammi Gaskins as next CEO October 16, 2026 7:30 AM - StreetInsider Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer October 16, 2026 7:30 AM - BizWire Form 144 IRONWOOD PHARMACEUTICALS Filed by: Shetzline Michael September 23, 2026 4:09 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Sep 15 Filed by: DENNER ALEXANDER J September 17, 2026 4:06 PM - SEC Filing Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:19 AM - SEC Filing Form SCHEDULE 13G IRONWOOD PHARMACEUTICALS Filed by: STATE STREET CORP August 7, 2026 9:58 AM - SEC Filing Form 10-Q IRONWOOD PHARMACEUTICALS For: Jun 30 August 6, 2026 4:10 PM - SEC Filing Form 8-K IRONWOOD PHARMACEUTICALS For: Aug 06 August 6, 2026 7:12 AM - SEC Filing Ironwood Pharma (IRWD) Misses Q2 EPS by 7c August 6, 2026 7:05 AM - StreetInsider Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results August 6, 2026 7:05 AM - BizWire Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call July 30, 2026 4:05 PM - BizWire Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: BlackRock, Inc. July 28, 2026 4:46 PM - SEC Filing Full Article List